Protagonist Therapeutics | 8-K:重大事件
Protagonist Therapeutics | 4:持股变动声明-高管 Ali Asif
Protagonist Therapeutics | 4:持股变动声明-董事 Waddill William D.
Protagonist Therapeutics | 144:拟议出售证券
Protagonist Therapeutics | 144:拟议出售证券
Protagonist Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(18.2%)
Protagonist Therapeutics | 10-Q:2024财年二季报
Protagonist Therapeutics | 8-K:主角公布2024年第二季度财务业绩并提供公司最新情况
Protagonist Therapeutics | 4:持股变动声明-董事 Waddill William D.
Protagonist Therapeutics | 144:拟议出售证券
Protagonist Therapeutics | 8-K:重大事件
Protagonist Therapeutics | 4:持股变动声明-高管 PATEL DINESH V PH D
Protagonist Therapeutics | 4:持股变动声明-高管 PATEL DINESH V PH D
Protagonist Therapeutics | 4:持股变动声明-董事 Waddill William D.
Protagonist Therapeutics | 144:拟议出售证券
Protagonist Therapeutics | 144:拟议出售证券
Protagonist Therapeutics | 10-Q:2024财年一季报
Protagonist Therapeutics | 8-K:主角公布2024年第一季度财务业绩并提供公司最新情况
Protagonist Therapeutics | ARS:年度报告
Protagonist Therapeutics | DEFA14A:其他
暂无数据
暂无数据